Cameco Co. (NYSE:CCJ) Shares Sold by American Trust Investment Advisors LLC

American Trust Investment Advisors LLC cut its stake in Cameco Co. (NYSE:CCJ - Free Report) TSE: CCO by 34.5% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 92,629 shares of the basic materials company's stock after selling 48,865 shares during the period. Cameco accounts for about 2.1% of American Trust Investment Advisors LLC's portfolio, making the stock its 20th largest position. American Trust Investment Advisors LLC's holdings in Cameco were worth $3,992,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors also recently bought and sold shares of CCJ. Principal Securities Inc. purchased a new stake in shares of Cameco in the fourth quarter worth about $29,000. Allworth Financial LP increased its holdings in shares of Cameco by 1,049.2% during the 3rd quarter. Allworth Financial LP now owns 747 shares of the basic materials company's stock valued at $30,000 after purchasing an additional 682 shares in the last quarter. Versant Capital Management Inc acquired a new position in shares of Cameco in the 4th quarter valued at $34,000. Sandy Spring Bank purchased a new stake in Cameco during the fourth quarter worth $43,000. Finally, Blue Trust Inc. grew its position in Cameco by 57.5% during the fourth quarter. Blue Trust Inc. now owns 1,427 shares of the basic materials company's stock valued at $57,000 after buying an additional 521 shares during the period. Hedge funds and other institutional investors own 70.21% of the company's stock.

Cameco Price Performance

Shares of NYSE CCJ traded down $0.28 during midday trading on Tuesday, hitting $53.72. The stock had a trading volume of 3,580,647 shares, compared to its average volume of 4,904,451. The company has a quick ratio of 0.69, a current ratio of 1.42 and a debt-to-equity ratio of 0.17. The stock has a 50 day simple moving average of $47.20 and a 200-day simple moving average of $45.32. The company has a market capitalization of $23.35 billion, a PE ratio of 137.77 and a beta of 0.92. Cameco Co. has a 1 year low of $26.15 and a 1 year high of $54.93.

Cameco (NYSE:CCJ - Get Free Report) TSE: CCO last announced its quarterly earnings data on Tuesday, April 30th. The basic materials company reported $0.10 earnings per share for the quarter, missing analysts' consensus estimates of $0.33 by ($0.23). The firm had revenue of $470.29 million during the quarter. Cameco had a net margin of 9.28% and a return on equity of 4.60%. On average, sell-side analysts expect that Cameco Co. will post 1.37 EPS for the current fiscal year.

Analysts Set New Price Targets

Several research firms have recently issued reports on CCJ. StockNews.com lowered shares of Cameco from a "hold" rating to a "sell" rating in a research note on Thursday, April 4th. The Goldman Sachs Group initiated coverage on Cameco in a research report on Monday, April 1st. They set a "buy" rating and a $55.00 price target on the stock. One analyst has rated the stock with a sell rating, one has issued a hold rating, two have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus target price of $62.75.

Cameco Company Profile

Cameco Corporation provides uranium for the generation of electricity. It operates through Uranium, Fuel Services, Westinghouse segments. The Uranium segment is involved in the exploration for, mining, and milling, purchase, and sale of uranium concentrate. The Fuel Services segment engages in the refining, conversion, and fabrication of uranium concentrate, as well as the purchase and sale of conversion services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.